TAO Synergies Inc. (TAOX)

Stammdaten

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

Unternehmen & Branche

NameTAO Synergies Inc.
TickerTAOX
CIK0001571934
BoerseUS
SektorHealthcare
IndustrieBiotechnology

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock
Marktkapitalisierung16,4 Mio. USD
Beta1,74
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K299,061-28,737,448-8.8125,835,02121,051,481
2025-09-3010-Q203,371-3,923,247-1.5618,358,98716,065,144
2025-06-3010-Q3,962-17,516,078-11.2619,791,57517,249,665
2025-03-3110-Q385,1690.0415,329,3095,168,789
2024-12-3110-K0-12,768,549-10.9917,733,7795,863,682
2024-09-3010-Q-5,742,013-5.0122,826,33712,801,972
2024-06-3010-Q-1,273,309-1.1828,385,21418,796,602
2024-03-3110-Q-206,699-0.4129,399,24822,052,981
2023-12-3110-K-6,038,50429.5631,113,66724,347,258
2023-09-3010-Q763,2030.8432,360,45826,740,860
2023-06-3010-Q-4,093,9541.3933,437,16524,830,127
2023-03-3110-Q-1,711,784-6.5936,529,42931,464,396
2022-12-3110-K-5,573,957-0.8138,607,80632,692,973
2022-09-3010-Q-3,026,4760.4327,350,64226,667,047
2022-06-3010-Q-3,751,9040.5429,579,25228,953,273
2022-03-3110-Q-3,277,9220.4732,353,32631,683,988
2021-12-3110-K-12,611,1972.5135,524,66033,529,748
2021-09-3010-Q-2,926,9330.4732,358,64231,351,313
2021-06-3010-Q-2,293,8420.5832,959,96932,189,996
2021-03-3110-Q-3,154,3771.0616,346,64815,409,208

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×